Mirum Pharmaceuticals, Inc. (MIRM) vs PTC Therapeutics, Inc. (PTCT)
Mirum Pharmaceuticals, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. is the larger, with a market value of $5.8B against $5.2B — 1.1× the size. Mirum Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 44.0% against −42.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −139.2%) and the higher return on invested capital (15.2% vs −173.0%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 12 and Mirum Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | MIRM | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 92.99% | 65.16% |
| Operating margin | (134.93%) | 12.45% | 0.00% |
| Net margin | (139.18%) | (3.80%) | 0.00% |
| Free cash flow margin | (44.29%) | (29.76%) | 0.00% |
| Return on equity | (702.97%) | 20.64% | (57.72%) |
| Return on assets | (97.15%) | (1.30%) | (49.22%) |
| Return on invested capital | (172.96%) | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack